AstraZeneca 2020: Driven by Covid-19
Roche 2020: Built for innovation
Trump’s Treatments: Regeneron’s Antibodies and Gilead’s Remdesivir Explained
Trump Urges Stimulus Deal Via Tweet As MSM Reports His Condition "Far More Dire" Than White House Says
Trump treated with experimental antibody cocktail for Covid-19
In a field where smaller is better, researchers discover the world’s tiniest antibodies
Fourth large-scale COVID-19 vaccine trial begins in the United States
UC study sheds light on cancer treatment, COVID-19
Regeneron tests COVID-19 antibody therapy in UK’s RECOVERY trial
Cytiva Plans $500M Expansion, 1,000 New Hires Worldwide
A ‘Human’ Touch vs. COVID-19
GSK and Vir take COVID-19 antibody therapy into clinic
Vir Bio and GSK Join the Race for a Covid-19 Monoclonal Antibody Therapy
AstraZeneca Initiates Early Trial Of Potential Covid-19 Antibody Treatment
African COVID-19 Cases Hit 1.2 Million As Dr. Fauci Urges FDA To 'Carefully Vet' Vaccines: Live Updates
Tuesday’s Pre-Market: Here’s What You Need To Know Before The Market Opens
Sorrento Ties The Knot With SmartPharm, Boosting Its Covid-19 Offering
9 reasons you can be optimistic that a vaccine for COVID-19 will be widely available in 2021
Tiziana Spikes 25% In Pre-Market On Patent Win For Foralumab
COVID-19 Prevention Network launches two research studies evaluating monoclonal antibodies
First patients in NIH ACTIV-3 clinical trial enroll in Dallas
NIH launches clinical trial to test antibody treatment in hospitalized COVID-19 patients
Next big COVID-19 treatment may be manufactured antibodies
Overcoming Scale-Up Challenges in Gene Therapy Manufacturing
Bill Gates discusses the coronavirus death rate
After Big Pharma abandoned infectious diseases, 5 biotech contrarians decided to go all in. Then Covid-19 changed everything
Columbia Team ID Potent SARS-CoV-2 Antibodies to Neutralize the Virus
Potent SARS-CoV-2 Antibodies from Patients Show Promise
GSK Buys 10% Stake In Germany’s CureVac To Develop mRNA Vaccines
Researchers develop new tools to rapidly test activity of anti-coronavirus antibodies